These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 23229280

  • 1. Role of KCNJ5 in familial and sporadic primary aldosteronism.
    Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA.
    Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280
    [Abstract] [Full Text] [Related]

  • 2. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA, Monticone S, Schack VR, Stindl J, Burrello J, Buffolo F, Annaratone L, Castellano I, Beuschlein F, Reincke M, Lucatello B, Ronconi V, Fallo F, Bernini G, Maccario M, Giacchetti G, Veglio F, Warth R, Vilsen B, Mulatero P.
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [Abstract] [Full Text] [Related]

  • 3. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI, Lifton RP.
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [Abstract] [Full Text] [Related]

  • 4. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
    Murthy M, Xu S, Massimo G, Wolley M, Gordon RD, Stowasser M, O'Shaughnessy KM.
    Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
    [Abstract] [Full Text] [Related]

  • 5. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
    Shalomov B, Handklo-Jamal R, Reddy HP, Theodor N, Bera AK, Dascal N.
    J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562
    [Abstract] [Full Text] [Related]

  • 6. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
    Monticone S, Hattangady NG, Penton D, Isales CM, Edwards MA, Williams TA, Sterner C, Warth R, Mulatero P, Rainey WE.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
    [Abstract] [Full Text] [Related]

  • 7. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M, Caroccia B, Stindl J, Bandulik S, Lenzini L, Gioco F, Fishman V, Zanotti G, Gomez-Sanchez C, Bader M, Warth R, Rossi GP.
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [Abstract] [Full Text] [Related]

  • 8. [Primary aldosteronism: new insights into familial forms].
    van den Meiracker AH, van der Linde AA, Claahsen van der Grinten HL, Danser AH, Deinum J.
    Ned Tijdschr Geneeskd; 2015 Sep; 159():A8932. PubMed ID: 26420144
    [Abstract] [Full Text] [Related]

  • 9. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
    Mulatero P, Tauber P, Zennaro MC, Monticone S, Lang K, Beuschlein F, Fischer E, Tizzani D, Pallauf A, Viola A, Amar L, Williams TA, Strom TM, Graf E, Bandulik S, Penton D, Plouin PF, Warth R, Allolio B, Jeunemaitre X, Veglio F, Reincke M.
    Hypertension; 2012 Feb; 59(2):235-40. PubMed ID: 22203740
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE.
    Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
    [Abstract] [Full Text] [Related]

  • 13. Primary aldosteronism and potassium channel mutations.
    Stowasser M.
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):170-9. PubMed ID: 23426162
    [Abstract] [Full Text] [Related]

  • 14. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
    Aristizabal Prada ET, Castellano I, Sušnik E, Yang Y, Meyer LS, Tetti M, Beuschlein F, Reincke M, Williams TA.
    Int J Mol Sci; 2018 Apr 09; 19(4):. PubMed ID: 29642543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Familial hyperaldosteronism type III a novel case and review of literature.
    Pons Fernández N, Moreno F, Morata J, Moriano A, León S, De Mingo C, Zuñiga Á, Calvo F.
    Rev Endocr Metab Disord; 2019 Mar 09; 20(1):27-36. PubMed ID: 30569443
    [Abstract] [Full Text] [Related]

  • 18. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.
    Charmandari E, Sertedaki A, Kino T, Merakou C, Hoffman DA, Hatch MM, Hurt DE, Lin L, Xekouki P, Stratakis CA, Chrousos GP.
    J Clin Endocrinol Metab; 2012 Aug 09; 97(8):E1532-9. PubMed ID: 22628607
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.